Litigation Details for CELGENE CORPORATION v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2018)
✉ Email this page to a colleague
CELGENE CORPORATION v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2018)
Docket | ⤷ Try a Trial | Date Filed | 2018-04-27 |
Court | District Court, D. New Jersey | Date Terminated | |
Cause | 15:1126 Patent Infringement | Assigned To | Susan Davis Wigenton |
Jury Demand | None | Referred To | Leda D. Wettre |
Patents | 7,465,800; 7,855,217; 7,968,569; 8,530,498; 8,648,095; 9,101,621; 9,101,622 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in CELGENE CORPORATION v. ZYDUS PHARMACEUTICALS (USA) INC.
Details for CELGENE CORPORATION v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | 1 | United States Patent Nos. 7,465,800 (the “’800 patent”), 7,855,217 (the “’217 patent”), 7,968,569 (the…of United States Patent Nos. 7,977,357 (the “’357 patent”), 8,193,219 (the “’219 patent”), and 8,431,598…(the “’569 patent”), 8,530,498 (the “’498 patent”), 8,648,095 (the “’095 patent”), 9,101,621 (the “’621… 1. This is an action for patent infringement under the patent laws of the United States, 35 U.S.C…,598 (the “’598 patent”), all owned by Celgene (collectively, “the patents-in-suit”). | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |